Preliminary Program: Monday, May 21
7 a.m.-8:30 a.m.
Industry-Supported Symposia
IS21. Lifting the Burden of Psychiatric Illness: The Management of Allostatic Load, Metabolic Syndrome, and Co-Occurring DisordersSupported by Solvay-Wyeth
To Be Announced Alicia Ruelaz, M.D. | |||||
To Be Announced Kathleen T. Brady, M.D. | |||||
Psychotropic Medications, Psychiatric Illness, and Weight Gain Rohan Ganguli, M.D. | |||||
The Heart of the Matter: Allostatic Load and Psychiatric Disorders Robert B. Lydiard, M.D. | |||||
Integrating Alternative Health Approaches Into the Care of Our Patients: Evidence About the Actions of Exercise, Massage, and Acupuncture Mark H. Rapaport, M.D. | |||||
IS22. How Do Atypicals and Antipsychotics Work? From Receptors to RealitySupported by Bristol-Myers Squibb Co.
How Antipsychotics Work—Linking Pharmacology to Phenomenology Shitij Kapur, M.D., Ph.D. | |||||
Improving Long-Term Outcomes of Patients With Psychotic Disorders John Lauriello, M.D. | |||||
From Receptors to Reality: Deconstructing the Neurobiology Behind Schizophrenia Gordon Frankle, M.D. | |||||
Achieving Clinical Success: Pharmacologic Predictability of Adverse Events Lenard A. Adler, M.D. | |||||
IS23. Treating the Spectrum of Bipolar Disorders: An Interactive Case DiscussionSupported by AstraZeneca Pharmaceuticals
Psychotherapy and Bipolar Depression Holly Swartz, M.D. | |||||
Antidepressants in Bipolar Depression: A Two-Sided Story Michael E. Thase, M.D. | |||||
Beyond Antidepressants: Treatment Options for Bipolar Depression Roger S. McIntyre, M.D. | |||||
Treating and Preventing Mania Lauren B. Marangell, M.D. | |||||
8 a.m.-Noon
CME Courses 33-40
8 a.m.-5 p.m.
CME Course 41
9 a.m.-4 p.m.
CME Courses 42-48
9 a.m.-10:30 a.m.
Case Conference
Glen O. Gabbard, M.D., on Psychodynamic Psychotherapy of Borderline Personality Disorder
9 a.m.-10:30 a.m.
Component Workshops
CW1. A Model Curriculum for Teaching the Working Alliance as a Core Process Across PsychotherapiesAPA Committee on Psychotherapy by Psychiatrists; Chair: Eric M. Plakun, M.D.
CW2. Reentry After Prison: Rejoining the CommunityAPA Corresponding Committee on Jails and Prisons; Chair: Henry C. Weinstein, M.D.
CW3. Committing Occupational Suicide: A Psychiatric EmergencyAPA Corresponding Committee on Psychiatry in the Workplace; Chair: Andrea Stolar, M.D.
CW4. Providing Optimum Care for Patients With Mental Retardation and Developmental Disabilities in the Psychiatric Emergency RoomAPA Committee on Developmental Disabilities; Chair: Katharine A. Stratigos, M.D.
CW5. Obesity in Our Youth: The Weight of Mental IllnessAPA/SAMHSA Minority Fellowship Selection and Program Corresponding Committee; Chair: Jodi E. Star, M.D.
CW6. How to Become a More Creative Teacher: Winning Strategies for Residents and FacultyAPA Council on Medical Education and Lifelong Learning; Chair: Joan M. Anzia, M.D.
CW7. Beyond Powerpoint: How Technology Can Improve Mental Health TrainingAPA Ad Hoc Work Group on Information Systems; Chair: Seth Powsner, M.D.
CW8. Mental Health Transformation: Is It for Real?APA Committee on Psychiatric Administration and Management; Chair: L. Mark Russakoff, M.D.
CW9. Mental Health and Men Who Have Sex With Men in the African-American Community: Controversies About the “Down Low”APA Committee on Gay, Lesbian, and Bisexual Issues; Chair: Lourdes M. Dominguez, M.D.
CW10. Gender and Culture in Academic Leadership: Improving the Current State for WomenAPA Women Psychiatrists; Chair: Roslyn Seligman, M.D.
CW11. Optimizing Depression Treatment: Clinical Applications of Measurement-Based CareAPA American Psychiatric Institute for Research and Education; Chair: David J. Katzelnick, M.D.
CW12. Reaching Out: Approaches to Suicide Amongst the Physician PopulationAPA Corresponding Committee on Physician Health, Illness, and Impairment; Chair: Malkah T. Notman, M.D.
Focus Live
Stephen Stahl, M.D., on Psychopharmacology
Issue Workshops
IW1. Headspace Theatre: An Innovative Method for Experiential Learning of Psychiatric Symptomatology Using Modified Role-Playing and Improvisational Theatre TechniquesAssociation for Academic Psychiatry; Chair: Bruce Ballon, M.D.
IW2. Risk Management Issues in Psychiatric PracticeChair: Jacqueline M. Melonas, J.D.
IW3. Children of PsychiatristsChair: Michelle B. Riba, M.D.
IW4. Psychiatry and the Medical HumanitiesChair: Bret R. Rutherford, M.D.
IW5. Lessons From Teaching Interviewing to International Residents: Integrating Cultural Competency From the Start of TrainingChair: Jacob Sperber, M.D.
IW6. Grantwriting Workshop: Research Funding Opportunities From the National Institute on Drug AbuseNational Institute on Drug Abuse; Chair: Lucinda L. Miner, Ph.D.
IW7. Gene-Environment-Development Interactions: Implications for Psychiatric and Substance Abuse DisordersNational Institute on Drug Abuse; Chair: Jonathan D. Pollock, Ph.D.
IW8. Assessment of Capacity: A Multimedia Approach to Enhancing Clinical Skills in Different Cultural and Legal SettingsChair: M.E. Jan Wise, M.B.Ch.B.
IW9. Prevention of Burden and Burnout in Caregivers at Home and Health Care Workers in Long-Term-Care SettingsChair: Sanjay M. Vaswani, M.D.
IW10. Going to the Heart of the Matter in Patient Interviews: A Further ExplorationChair: Harold J. Bursztajn, M.D.
IW11. Practical Pharmacotherapy for the Treatment of Alcohol DependenceNational Institute on Alcohol Abuse and Alcoholism; Chair: Robert M. Swift, M.D.
IW12. The Trauma of War: Understanding Interventions in a Developmental ContextChair: Alisa J. Land, M.D.
IW13. Metabolic Screening of Patients on Antipsychotic Medications: Implementation of a Quality Improvement Program in an Urban Training ClinicChair: Diane B. Gottlieb, M.D.
IW14. Internet Child Pornography and Mental Illness: The Psychiatrist's RoleChair: Humberto Temporini, M.D.
IW15. Challenging the Status Quo: Centralized Assessments in Psychiatric Clinical TrialsChair: John M. Kane, M.D.
IW16. Achieving Medication Adherance by Understanding RecoveryChair: Stephen N. Wilson, M.D.
Lectures
L2.David C. Henderson, M.D., APA's Solomon Carter Fuller Award Lecture
L3. The Road to Equity: Marching Toward a Just Treatment of Mental Illness and Addiction in AmericaU.S. Rep. Patrick Kennedy, Outside Lecture Series
L4. A Neurotrophic Hyothesis of Depressions and Antidepressant ResponseRonald Duman, Ph.D., Frontiers of Science Lecture Series
Small Interactive Sessions
1. Meet the Author Joel Yager, M.D.
9 a.m.-Noon
Case Conference
Judith S. Beck, Ph.D., on Cognitive Therapy for Depression
Media Workshops
MP1. Personal Transformation Through an Encounter With Death: Akira Kurosawa's “Ikiru”Chair: Francis G. Lu, M.D.
MP2. “Brokeback Mountain”: The Myth, the Reality, and the ControversyAPA New York County District Branch's Committee on Gay and Lesbian Issues; Chair: Kenneth Ashley, M.D.
11 a.m.-12:30 p.m.
Advances in Medicine
AM01. New Integrative Treatments for PTSD and Chronic Fatigue, Disorders of Autonomic FunctionRichard P. Brown, M.D.
Component Workshops
CW13. Advocacy Training for Early Career Psychiatrists With a Focus on Parity LegislationAPA Assembly Committee of Early Career Psychiatrists; Chair: Carol L. Trippitelli, M.D.
CW14. Uncovering the Secret: Intimate Partner Violence Among Asian AmericansAPA Asian-American Psychiatrists; Chair: Surinder S. Nand, M.D.
CW15. Controversies in the Management of Behavioral Disturbance in DementiaAPA Committee on Access and Effectiveness of Psychiatric Services for the Elderly; Chair: David A. Casey, M.D.
CW16. Multinational Perspectives of Psychiatric EthicsAPA Ethics Appeals Board; Chair: Donna M. Norris, M.D.
CW17. How to Teach Cultural Competence in Geriatric Psychiatry: Addressing Unmet Patient NeedsAPA Committee on Ethnic Minority Elderly; Chair: Maria D. Llorente, M.D.
CW18. Providing Services to Mentally Ill Inmates Returning to the CommunityAPA Task Force on Forensic OutpatientServices; Chair: Steven K. Hoge, M.D.
CW19. Boot Camp for BurnoutAPA Representatives of Minority/Underrepresented Groups; Chair: Altha J. Stewart, M.D.
CW20. The Impact of Violence in Latino CommunitiesAPA Committee of Hispanic Psychiatrists; Chair: Andres J. Pumariega, M.D.
CW21. Conceptualizing Access to Psychiatric CareAPA Access to Care Work Group; Chair: Eliot Sorel, M.D.
CW22. Pearls and Pitfalls in Negotiating Your First JobAPA Committee of Residents and Fellows; Chair: Justin B. Hunt, M.D.
Focus Live
Thomas R. Kosten, M.D., on Substance-Related Disorders
Issue Workshops
IW17. The Dilemma of Women's Professional Garments and ProfessionalismChair: Katharine A. Stratigos, M.D.
IW18. Dynamic Therapy With Self-Destructive Borderlines;Chair: Eric M. Plakun, M.D.
IW19. First-Episode Mood Disorders: What Have We Learned and Where Do We Go From Here?Chair: Kathryn J. Macdonald, M.D.
IW20. Teaching Cognitive-Behavior Therapy to Child and Adult ResidentsChair: Judith S. Beck, Ph.D.
IW21. American Board of Psychiatry and Neurology Update: Certification and Maintenance of Certification in Psychiatry and Its SubspecialtiesChair: Larry R. Faulkner, M.D.
IW22. Assessing Capacity to Drive: A Practical Approach to the Psychiatrist's Role and ResponsibilitiesChair: Dimitri D. Markov, M.D.
IW23. Implementing a Telepsychiatry Program in the Kern County Mental Health System in Rural CaliforniaChair: Tai Pyung Yoo, M.D.
IW24. Women Residents' Needs During Psychiatric TrainingChair: Anu A. Matorin, M.D.
IW25. The Earliest Environment: Prenatal Stress, Anxiety, and Depression and Child OutcomeChair: Hanna E. Stevens, M.D.
IW26. Detection of MalingeringChair: Alan R. Hirsch, M.D.
IW27. Music as a Means of Survival: The Significance of Music in Surviving the HolocaustChair: Andrei Novac, M.D.
Lectures
L5. Spiritus Contra Spiritum: The Strange Case of Spirituality and AddictionWilliam R. Miller, M.D., APA Corresponding Committee on Religion, Spirituality, and Psychiatry, APA's Oskar Pfister Award Lecture
L6.APA's Administrative Psychiatry Award Lecture
L7.Mary J. Kreek, Ph.D., Frontiers of Science Lecture Series
Scientific and Clinical Reports Session 1. President's Theme: Addressing Patient Needs: Access, Parity, and Humane Care
1. The Discourse of Health Care Economics David A. Rothstein, M.D.
2. Medicare Part D Prescription Drug Benefits: Impact on Medication Access and Continuity Among Dual-Eligible Psychiatric Patients Joyce C. West, Ph.D.
3. Dealing With Disaster Mental Health Russell F. Franco D'Souza Sr., M.D.
Session 2. Compulsive and Addictive Behaviors
4. Association of Cannabis Use With Prodromal Features of Psychosis and Behavioral Problems in Adolescence Juha M. Veijola, M.D.
5. Paternal Alcoholism Predicts Alcohol Dependence But Not Recovery After 40 years Joachim Knop, M.D.
6. Self-Loathing and Perfectionism: Linking Eating Disorders and Compulsive Exercise Alayne Yates, M.D.
Session 3. OCD
7. Capsulotomy in Refractory OCD: Long-Term Outcome in 25 Patients Christian Rück, M.D.
8. Trichotillomania in Youth: A Naturalistic Outcome Study Catherine L. Mancini, M.D.
9. Obsessive-Compulsive Disorder in Psychiatric Outpatients: Prevalence, Comorbidity, and Demographic and Clinical Characteristics Charlotte A.L. Rocker, B.S.
Session 4. Metabolic Disorders and Psychosis
10. Second-Generation Antipsychotics and Diabetes Mellitus: Risk, Number Needed to Harm, and Clinical Impact Leslie L. Citrome, M.D.
11. Metabolic Risks in Psychosis in Sweden Urban Ösby, M.D.
12. Effect of Body Weight and Metabolic Complications on Health-Related Quality of Life in Swedish Outpatients With Schizophrenia Signy Reynisdottir, M.Div.
Session 5. Legal Issues in Psychiatry
13. Understanding Filicide Sara G. West, M.D.
14. Testimonies of APA and ANA Presidents in the Harry Thaw “Brain Storm” Defense: Temporary Insanity One Hundred Years Ago in 1907 Emil R. Pinta, M.D.
15. Correctional Mental Health Care in a Large, Urban Jail: Challenges and Opportunities Amina Abdulla, M.D.
Session 6. Anxiety Disorders
16. Treatment Outcome of Panic Disorder and Agoraphobia in a Naturalistic Clinical Setting John K. Lam-Po-Tang, M.B.B.S.
17. Panic Disorder With Social Anxiety Disorder Comorbidity: Difference of Response to Low vs. High Doses of Clonazepam Antonio E. Nardi, M.D.
18. The Relationship Between Functional Outcomes and Treatment of Anxious and Painful Somatic Symptoms in Patients With Generalized Anxiety Disorder David V. Sheehan, M.D.
Session 7. Attention Spectrum Disorders
19. Circadian Rhythm Disturbances in Attention-Deficit/Hyperactivity Disorder George A. Keepers, M.D.
20. Is Comorbid Adult Attention-Deficit Disorder Prevalent in Psychiatric Outpatients? John A. Gergen, M.D.
21. Extended Duration of Action of SPD465, a 16-Hour Mixed Amphetamine Salts Formulation, in the Treatment of Adults With ADHD Thomas J. Spencer, M.D.
Session 8. Child and Adolescent Psychiatry
22. Quality of Care for Children and Adolescents: Access to Psychotherapy Farifteh F. Duffy, Ph.D.
23. Adolescent Depression and Its Relationship to School Dropouts and Accidents on University Campus Chih-Wei Yang, M.D.
24. Insulin Resistance in Adolescent Subjects at Risk for Psychosis Hannu J. Koponen, M.D.
Session 9. Psychiatric Impact of Medical Conditions
25. Severe Headaches and the Risk of Subsequent Suicidal Thoughts or Behaviors Stephen B. Woolley, D.Sc.
26. Modafinil Improves Behavioral Alertness in Patients With Residual Excessive Sleepiness Following Nasal Continuous Positive Airway Pressure-Treated Obstructive Sleep Apnea David F. Dinges, Ph.D.
27. Effect of Sildenafil on Erectile Function and Depression: Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies in Men With Erectile Dysfunction and Treated or Untreated Depression Joseph Cappelleri, Ph.D.
Small Interactive Sessions
1. Meet the Author Arnold Cooper, M.D.
2. Meet the Author Sandra Jacobson, M.D.
Noon-12:30 p.m.
Forum
1. On the Frontline in America: Treating Violent Patients and the Ethics of Providing CareChair: Paul S. Appelbaum, M.D.
Noon-1:30 p.m.
Forums
2. Research Planning forDSM-V APA Committee on Psychiatric Diagnosis and Assessment; Chair: Darrel A. Regier, M.D.
3. Piano ForumChair: Richard Kogan, M.D.
4. Autobiography/Biography Young Adult: Metaphors for Putting a Face on Human HistoryChair: JoAnne Isbey, A.B.D.
5. Substance Abuse and Your Patients: Beyond What Is Taught in Your ResidencyChair: Nora Volkow, M.D.
1 p.m.-5 p.m.
CME Courses 49-54
2 p.m.-3:30 p.m.
Focus Live
John Kelsoe, M.D., on Genetics and Psychiatry
Lectures
L8.Stephen C. Scheiber, M.D., APA/NIMH Vestermark Award Lecture
L9. Advancing Paternal Age and Offspring Risks for Psychiatric Disorders: A Translational PerspectiveDolores Malaspina, M.D., Distinguished Psychiatrist Lecture Series
L10. The Healing Power of Electroconvulsive TherapyKitty Dukakis
2 p.m.-5 p.m.
Presidential Symposia
1. The Role of Ethics in World PsychiatryAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.
2. Women Leaders in APA and BeyondAPA Committee on Women; Chair: Pedro Ruiz, M.D.
Symposia
S1. Schizophrenia With Comorbid Conditions: Clinical Issues
To Be Announced Siegfried Kasper, M.D. | |||||
Schizophrenia With Obsessive-Compulsive and Panic Symptoms: Treatment Issues Michael Y. Hwang, M.D. | |||||
Eating Disorder Comorbidity in Schizophrenia: Clinical Implications for Managing Obesity and Metabolic Disorders Sun Young Yum, M.D. | |||||
Recent Increments in Knowledge About Suicidality in Schizophrenia Alec Roy, M.D. | |||||
S2. Biological Foundations of Bipolar Disorder: New Insights and Prospects for Treatment
Cognition, Neuroplasticity, and Treatment of Bipolar Disorder Eduard Vieta, M.D. | |||||
Is the Protein Kinase C Inhibition a Keystone in Treatment of Bipolar Disorder? Aysegul Yildiz-Yesiloglu, M.D. | |||||
Glial Cell Dysfunction in the Pathophysiology of Bipolar Disorder Dost Ongur, M.D., Ph.D. | |||||
Genetics of Bipolar Disorder: Recent Advances and Coming Attractions Jordan W. Smoller, M.D. | |||||
S3. Physical Illness in People With Severe Mental Disorders
Physical Illness and Mental Disorder: Neglected Facts Norman H. Sartorius, M.D. | |||||
Physical Illness and Schizophrenia: Extensive Review of the Literature Stefan Leucht, M.D. | |||||
Diabetes and Mental Disorders: What Do We Know About Risks and Linkages? Michelle B. Riba, M.D. | |||||
Physical Illness in Patients With Mental Disorders Seen in Anambra, Nigeria Richard Uwakwe, M.B.B.S. | |||||
S4. Suicide Across the Life Cycle: A Spanish-Language Update (Manejo y Tratamiento del Paciente Suicida en las Distintas Etapas de la Vida)
Neurobiological Correlates of Suicide Pedro L. Delgado, M.D. | |||||
Youth Suicide (Suicidio Infantojuvenil) Gabriel Kaplan, M.D. | |||||
To Be Announced Maria A. Oquendo, M.D. | |||||
Suicidal Behavior in Late Life Jacobo E. Mintzer, M.D. | |||||
Suicide in the Medically Ill Humberto Marin, M.D. | |||||
S5. Insights on Obesity and Drug Addiction From Brain Imaging
Modulators of Orbitofrontal Activation in Response to Food Stimuli Deborah Yurgelun-Todd, Ph.D. | |||||
Hunger as an Addiction Alain Dagher, M.D. | |||||
Application of Incentive-Sensitization Theory of Drug Addiction to Over-eating Dana M. Small, Ph.D. | |||||
Neuroimaging Studies of Obesity and Drug Addiction Gene-Jack Wang, M.D. | |||||
S6. Treatments for Maladaptive Personality Traits With Some Empirical Support
The Effect of Axis II on Outcome of Axis I Disorders James H. Reich, M.D. | |||||
Initial Findings From the Canadian RCT of Dialectical Behavior Therapy for BPD Paul Links, M.D. | |||||
The STEPPS Model: A Cognitive Group Treatment for BPD Donald W. Black, M.D. | |||||
Schema-Focused Therapy: An Evidence-Based Treatment for Borderline Personality Disorder David P. Bernstein, Ph.D. | |||||
Pharmacologic Treatment of Personality Disorder Traits Kenneth R. Silk, M.D. | |||||
S7. Neuroscience and Phenomenology of Schizophrenia
The History of the Phenomenological Method in Clinical Psychiatry Otto F. Doerr Zegers, M.D. | |||||
Neurodevelopmental Disruption of Hippocampal-Prefrontal Cortical Synaptic Connectivity: Implications for Schizophrenia Pathophysiology Kuei-Yuan Tseng, Ph.D. | |||||
To Be Announced Michael A. Schwartz, M.D. | |||||
From the Neurobiology of Adolescence to the Neurobiology of Early Schizophrenia Rodrigo D. Paz, M.D. | |||||
S8. How to Practice Sport Psychiatry: A Demonstration
The Overview of the Field of Sport Psychiatry Ira D. Glick, M.D. | |||||
The ADHD-Affected Athlete and Role of the Psychiatrist David O. Conant-Norville, M.D. | |||||
Interviewing the Athlete With a Substance Abuse Problem Ronald L. Kamm, M.D. | |||||
The Athlete With Depression—Understanding Etiology and Treatment Through the Interview Antonia L. Baum, M.D. | |||||
S9. CRF Antagonism for Treatment of Alcoholism and Affective Disorders
Getting There, or Being There Already: Alcohol-Induced Neuroadaptations and Genetic Susceptibility Can Both Result in a Recruitment of the CRF System Underlying Excessive Drinking and Relapse Markus Heilig, M.D. | |||||
The Dark Side of Alcoholism: Neuroadaptational Mechanisms With the CRF System Critical for Excessive Drinking George F. Koob, Ph.D. | |||||
Amygdala Protein Kinase C Epsilon Regulates Corticotropin Releasing Factor, Anxiety, and Alcohol Self-Administration Robert O. Messing, M.D. | |||||
Targeting the Corticotrophin Releasing Factor System for the Treatment of Alcohol Dependence Selena Bartlett, Ph.D. | |||||
Genetic Association of the Human Corticotropin Releasing Hormone Receptor 1 (CRHR1) With Binge Drinking and Alcohol-Intake Patterns in Two Independent Samples Gunter Schumann, M.D. | |||||
Genetic Variation at the CRH Locus and Its Association With Anxiety and Alcohol Consumption—Lessons From the Macaque Christina S. Barr, Ph.D. | |||||
S10. The California Mental Health Systems Act: Transforming Systems of Care to Reduce Mental Health Disparities
Overview of CA Mental Health Service Act Rachel Garcia Guerrero, M.S.W. | |||||
The Community Services and Supports Component of the MHSA: Evaluating Efforts to Address Disparities in Mental Health Katherine Elliott, Ph.D. | |||||
MHSA Workforce and Training: Cultural Competence and Disparities Reduction Sergio Aguilar-Gaxiola, M.D., Ph.D. | |||||
Prevention and Early Intervention in Underserved Populations: Opportunities for Change Katherine G. Ruiz-Mellott, M.D. | |||||
S11. Ethics, Human Rights, and Dynamic Psychiatry
Psychiatrists Should Not Consult on the Interrogation of Detainees Steven S. Sharfstein, M.D. | |||||
Ethical Implications of Big Pharma Stephen A. Green, M.D. | |||||
A Reorientation Toward Professionalism in Medicine: Our Ethics—Our Future Joseph P. Merlino, M.Div. | |||||
Ethical Issues in Sexual Conversion (“Reparative”) Therapies Jack Drescher, M.D. | |||||
Ethics in Residency Lea E. de Francisci Lis, M.D. | |||||
S12. Eating Disorders 2007: Expanding Biological and Clinical Perspectives
Anorexia Nervosa and Obsessive-Compulsive Disorder Walter H. Kaye, M.D. | |||||
How Stable Are Eating-Disorder Diagnoses? David B. Herzog, M.D. | |||||
Impulse-Control Disorders in Eating-Disordered Women Katherine A. Halmi, M.D. | |||||
Body-Image Concerns and the Desire for Plastic Surgery After Bariatric Surgery James E. Mitchell, M.D. | |||||
Eating Disorders in Late Life William J. Apfeldorf, M.D. | |||||
S13. Deconstructing Psychosis
Parsing Endophenotypes Across Psychotic Disorders: Toward a Refined Nosology of Psychoses Matcheri Keshavan, M.D. | |||||
Delusions in Unipolar and Bipolar Major Depression: Recommendations for the Revision of DSM-IV Mario Maj, M.D. | |||||
Deconstructing Psychosis: A Brain-Imaging Perspective Raquel E. Gur, M.D. | |||||
Epidemiological and Psychopathological Approaches Toward Psychotic Diagnoses in DSM-V Jim Van Os, Ph.D. | |||||
Presenter Pharmacology of Psychosis: Contrasting Schizophrenia With Bipolar I Disorder Carol A. Tamminga, M.D. | |||||
S14. Brief Therapies: An Update for Clinicians
Useful Tips for Psychotherapists From Research Roger P. Greenberg, Ph.D. | |||||
Formulation and Intervention in Time-Limited Dynamic Psychotherapy Hanna Levenson, Ph.D. | |||||
Cognitive Therapy Judith S. Beck, Ph.D. | |||||
S15. What Is the Directionality of the Onset of Comorbid Substance Use and Other Psychiatric Disorders?
Methodological Issues in Assessing the Directionality of the Onset of Substance Use and Other Comorbid Psychiatric Disorders Helena C. Kraemer, Ph.D. | |||||
Evidence of Directionality in Epidemiological Studies of Adults Ronald Kessler, Ph.D. | |||||
Genetic Factors and the Directionality of Comorbid Disorders Michael Vanyukov, Ph.D. | |||||
Developmental Models to Explain the Onset and Directionality of Comorbid Disorders Monique Ernst, M.D. | |||||
Treatment Implications of Determining the Directionality of Comorbid Disorders Edward V. Nunes, M.D. | |||||
S16. Categories and Dimensions in Clinical and Research Contexts of Diagnostic Classification for DSM-V
Severity Is the Most Important Dimension of Depression Michael E. Thase, M.D. | |||||
Anxiety Disorders Katherine Shear, M.D. | |||||
Dimensional Approaches to Diagnosing Addictive Disorders Wilson M. Compton, M.D. | |||||
A Dimensional Prototype for Borderline Personality Disorder Andrew E. Skodol, M.D. | |||||
Dimensional Approach to Major Psychoses Patricia Suppes, M.D. | |||||
S17. The Disruptive Physician: Rehabilitate or Retaliate?
Managing Disruptive Behavior in Physicians: The Experience of Ontario's Physician Health Program Michael Kaufmann, M.D. | |||||
To Be Announced Larry J. Harmon, Ph.D. | |||||
The Forensic Psychiatric Contribution to Assessing and Understanding Disruptive Physician Behavior Hy Bloom, M.D. | |||||
Disruptive Docs: How Are They? Eva C. Ritvo, M.D. | |||||
S18. Impulsivity: From Neurophenomenology to Treatment Options
Treatment of Impulsivity and Compulsivity Eric Hollander, M.D. | |||||
Pharmacological Challenge in Pathological Gambling Stefano Pallanti, M.D., Ph.D. | |||||
Searching for Endophenotypes in OCD Families: Results From Neuropsychology and Brain-Imaging Studies Naomi A. Fineberg, M.D. | |||||
Exploring Impulsivity and Compulsivity Using Neurocognitive Probes: Translational Approaches Samuel Chamberlain, Ph.D. | |||||
S19. The “Hidden” Diagnoses in Psychiatry: Implications for Training, Clinical Care, and Outcomes
The Importance of Early-Onset Psychiatric Disorders and Developmental Psychopathology for the Psychiatrist Daniel F. Connor, M.D. | |||||
Dysmorphology, Mental Illness, and Learning Disabilities: Genetic Syndromes With Behavioral Phenotypes Carolyn M. Drazinic, M.D. | |||||
Common Diagnostic Confusions, Addictions, Depression, and ASPD— Which Is Which? Victor Hesselbrock, Ph.D. | |||||
Recovering the Diagnosis of Posttraumatic Stress Disorder in Psychiatric Training Julian D. Ford, Ph.D. | |||||
Pay Attention: The Impact of ADHD in Adulthood Leighton Y. Huey, M.D. | |||||
S20. Psychiatric Practice in the Nursing Home
Nursing Home Consultation Olivera J. Bogunovic, M.D. | |||||
Research in the Skilled Nursing Facility: Is It Different? Sanjay Gupta, M.D. | |||||
Behavior Management Program Subramoniam Madhusoodanan, M.D. | |||||
To Be Announced Ronald Brenner, M.D. | |||||
S21. Children of Immigrants in the Changing Mosaic of the United States
A Personal Introduction Consuelo C. Cagande, M.D. | |||||
Children of Immigrants: An Overview R. Rao Gogineni, M.D. | |||||
Balancing Act Between Two Cultural Identities Alyssa S. Kwon, M.D. | |||||
An Immigrant Parental Journey—Trials, Tribulations, and Triumphs Dilip Ramchandani, M.D. | |||||
The Second Generation: Risks and Opportunities Andres J. Pumariega, M.D. | |||||
S22. Update on Supportive Psychotherapy
Theory of Supportive Psychotherapy Arnold Winston, M.D. | |||||
History of Supportive Psychotherapy Stephen J. Rojcewicz Jr., M.D. | |||||
Research on Supportive Psychotherapy in the Treatment of Borderline Personality Disorder David J. Hellerstein, M.D. | |||||
Use of Supportive Psychotherapy in Adjustment Disorders Roger Peele, M.D. | |||||
Teaching Supportive Psychotherapy to Psychiatric Residents Carolyn J. Douglas, M.D. | |||||
S23. First Break Schizophrenia in Francophone and Anglophone Countries: Treatment and Neuroimaging: Vive la Difference
Early Intervention in Psychosis: An Evidence-Based Reform Patrick D. McGorry, M.D. | |||||
Cannabis Use and Past Treatment in First Psychotic Episode Olivier J. Canceil, Psy.D. | |||||
Preventing Schizophrenia: An International Initiative Thomas H. McGlashan, M.D. | |||||
Evaluation of Hospital-Based Care for Schizophrenia Karen A. Ritchie, Ph.D. | |||||
Treatment of First-Episode Psychosis: Importance of Drug Selection and Early Intervention Jeffrey A. Lieberman, M.D. | |||||
Neuroimaging in Patients With First Psychotic Episode Sonia Dollfus, M.D. | |||||
S24. Challenges and New Developments in the Psychiatric Education of Medical Students
Psychiatric Stigma in Medical Student Education Steven C. Schlozman, M.D. | |||||
The Latent Curriculum and the Emotional Development of Medical Students Eric R. Marcus, M.D. | |||||
Ambulatory Experiences in the Psychiatry Clerkship Tamara L. Gay, M.D. | |||||
Interdisciplinary and Longitudinal Integration During Clinical Training Adam M. Brenner, M.D. | |||||
S25. Innovative Ways in Psychotherapy Supervision: The Short-Term Dynamic Therapy Experience
Innovative Ways in Psychotherapy Supervision: The Short-Term Dynamic Therapy Experience Amir E. Ettekal, M.D. | |||||
S26. Alexithymia and Emotional Dysregulation: From Theory to Clinical Practice
Depression and Alexithymia in Eating Disorders Maurice Corcos, M.D. | |||||
Relationships Between Alexithymia, Depression, and Dependent Personality Disorder Gwenole Loas, M.D. | |||||
Borderline Personality Disorder and Emotional Dysregulation Alexandra Pham-Scottez | |||||
Alexithymia and Self-Injurious Behavior: A Core Dimension? A Study on 692 Subjects Ludovic Gicquel, M.D. | |||||
Alexithymia in Infertile Women Claire Lamas, M.D. | |||||
To Be Announced Claire Perrin | |||||
2 p.m.-5:30 p.m.
Advances In
Advances in Treatments of Psychiatric Disorders Glen O. Gabbard, M.D.
5:30 p.m.-6:30 p.m.
Lecture
L11.John Nash, Ph.D., William C. Menninger Memorial Convocation Lecture
7 p.m.-10 p.m.
Industry-Supported Symposia
IS24. Improving Outcomes in Schizophrenia: Prodrome to RemissionSupported by Janssen Pharmaceutica and Research Foundation
Early Intervention in the Psychotic Prodrome: Has Its Time Come? Christoph U. Correll, M.D. | |||||
The Course of Brain Abnormalities in Schizophrenia: Can We Modify Them? Rene Kahn, M.D., Ph.D. | |||||
Can We Increase Rates of Response and Remission in Schizophrenia? John M. Kane, M.D. | |||||
IS25. Navigating the Complex Maze of Bipolar DisorderSupported by Pfizer Inc. and Organon Inc.
Managing the Bipolar Patient With Medical Comorbidities Andrea Fagiolini, M.D. | |||||
Tailoring Antipsychotic Treatment to the Complex Patient With Bipolar Disorder Paul E. Keck Jr., M.D. | |||||
Bringing Research to the Clinician: Lessons From STEP-BD Gary S. Sachs, M.D. | |||||
Diagnostic Pitfalls in Patients With Bipolar Disorder Prakash S. Masand, M.D. | |||||
IS26. When Endocrinology and Psychiatry Collide: What the Clinician Needs to Know About Antipsychotic-Induced Endocrine DisturbancesSupported by AstraZeneca Pharmaceuticals
To be Announced Ram Cooppan, M.B.Ch.B. | |||||
Antipsychotics and Metabolic Risk: What's the Problem and What's the Solution? John W. Newcomer, M.D. | |||||
To Be Announced Meera Narasimhan, M.D. | |||||
To Be Announced Peter F. Buckley, M.D. | |||||
IS27. Improving Depression Treatments: Bridging the Gap Between Research and Clinical PracticeSupported by Eli Lilly and Co.
Follow-up Care After Initiating Antidepressant Treatment: An Empirically Informed Approach Mark Zimmerman, M.D. | |||||
Optimizing Treatment Outcomes in Old-Age Depression Charles F. Reynolds, III, M.D. | |||||
Optimizing Care for Menopausal Symptoms: The Interface Between Psychiatry and Gynecology Hadine Joffe, M.D. | |||||
Considerations in the Treatment of Depressed Patients With Chronic Medical Conditions Gregory E. Simon, M.D. | |||||
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study: Lessons Learned Timothy Petersen, M.D.▪ | |||||
